Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.62 |
| ▸ | MAPT | P10636 | 9/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 10/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | APAF1 | O14727 | 1/20 | 0.57 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.57 |
| ▸ | CCR6 | P51684 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9555445 | 0.98 | GAA (0.61) | GAAMAPTMCL1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL8649799 | 0.98 | GAA (0.61) | GAAMAPTMCL1KMT2ALMNA | |
| Methylglyoxal SCHEMBL6013425 | 0.85 | GAA (0.51) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL15018298 | 0.80 | KMT2A (0.77) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL6527367 | 0.78 | GAA (0.65) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL15040701 | 0.77 | GAA (0.62) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL1268566 | 0.77 | GAA (0.62) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL8485540 | 0.77 | GAA (1.00) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL4197315 | 0.77 | GAA (0.62) | GAAMAPTMCL1KMT2ALMNA | |
| SCHEMBL1773293 | 0.77 | GAA (0.62) | GAAMAPTMCL1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3899034-B1 | METHODS FOR RNA ANALYSIS | CureVac SE (DE) | 2026-03-18 | — | — | EP | claimed |
| US-12029716-B2 | Derivatives of korormicin useful as antibiotics | Viotika Life Sciences (CA) | 2024-07-09 | — | — | US | claimed |
| WO-2024120884-A1 | AROMATIC AMINE MODIFIED ACID-OLEFIN COPOLYMER FOR LUBRICANTS | BASF SE (DE) | 2024-06-13 | — | — | WO | claimed |
| US-20220257555-A1 | DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS | Viotika Life Sciences Inc. (CA) | 2022-08-18 | — | — | US | claimed |
| US-20220073962-A1 | METHODS FOR RNA ANALYSIS | CUREVAC AG (DE) | 2022-03-10 | — | — | US | claimed |
| EP-3899034-A1 | METHODS FOR RNA ANALYSIS | CureVac AG (DE) | 2021-10-27 | — | — | EP | claimed |
| EP-3555246-B1 | MULTI-FUNCTIONAL OLEFIN COPOLYMERS AND LUBRICATING COMPOSITIONS CONTAINING SAME | AFTON CHEMICAL CORP (US) | 2020-11-25 | — | — | EP | claimed |
| WO-2020127959-A1 | METHODS FOR RNA ANALYSIS | CUREVAC AG (DE) | 2020-06-25 | — | — | WO | claimed |
| EP-3405554-B1 | LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND | CHEVRON ORONITE CO (US) | 2019-12-25 | — | — | EP | claimed |
| EP-3555246-A1 | MULTI-FUNCTIONAL OLEFIN COPOLYMERS AND LUBRICATING COMPOSITIONS CONTAINING SAME | Afton Chemical Corporation (US) | 2019-10-23 | — | — | EP | claimed |
| EP-0465031-A1 | Multifunctional viscosity index improvers | TEXACO DEVELOPMENT CORPORATION (US) | 1992-01-08 | — | — | EP | claimed |
| US-5075383-A | Graft and amine derivatized copolymer of ethyleneand alpha olefin | TEXACO INC. (US) | 1991-12-24 | — | — | US | claimed |
| US-5013469-A | Butylene-ethylene-styrene polymer reacted with maleic anhydride and aromatic polyamine | TEXACO INC. (US) | 1991-05-07 | — | — | US | claimed |
| US-5013468-A | Terpolymer of aminoalkyl acrylamide or acrylate, an acrylamide and an acrylate | TEXACO INC. (US) | 1991-05-07 | — | — | US | claimed |
| US-5013470-A | Antioxidant VII lubricant additive | TEXACO INC. (US) | 1991-05-07 | — | — | US | claimed |
| EP-0414343-A1 | VI improver, dispersant, and anti-oxidant additive and lubricating oil composition containing same | TEXACO DEVELOPMENT CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| EP-0396297-A2 | Dispersant - anti-oxidant additive and lubricating oil composition containing same | TEXACO DEVELOPMENT CORPORATION (US) | 1990-11-07 | — | — | EP | claimed |
| EP-0338672-A1 | Viscosity index improver, dispersant and anti-oxidant additive and lubricating oil composition containing same | TEXACO DEVELOPMENT CORPORATION (US) | 1989-10-25 | — | — | EP | claimed |
| US-4863623-A | VISCOSITY INDEX, GRAFT POLYMERS OF ETHYLENE MODIFIED WITH AMINE COMPOUND | TEXACO INC. (US) | 1989-09-05 | — | — | US | claimed |
| EP-0170414-A2 | Process for treating metal surface | Hitachi Chemical Co., Ltd. (JP) | 1986-02-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257555-A1 | DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS | HRH3, HRH1, OPRK1 | GAA 3521/4885MAPT 4535/4885MCL1 4399/4885 |
| US-12029716-B2 | Derivatives of korormicin useful as antibiotics | HRH3, HRH1, OPRK1 | GAA 3521/4885MAPT 4535/4885MCL1 4399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.